Case Studies

New Call-to-action

Featured Case Study

A mid-size specialty pharmaceutical company was interested in licensing promising early-stage compounds in order to add critical mass to its portfolio. To gain clarity about the available options, and which would be a ‘best fit’, they engaged Fuld + Company. As a result of our in-depth primary and secondary research, and resulting recommendations, the company in-licensed two early-stage compounds, one of which they have now successfully brought to market.

Read case study >

Looking for a specific example? Just ask us.

Request a Case Study >

Consumer Packaged Goods + Retail

New Call-to-action
New Call-to-action
New Call-to-action

Financial Services

New Call-to-action
New Call-to-action
New Call-to-action

Healthcare

New Call-to-action
New Call-to-action
New Call-to-action

Life Sciences

New Call-to-action
New Call-to-action
New Call-to-action

Manufacturing + Industrial

New Call-to-action
New Call-to-action
New Call-to-action

Technology + Telecom

New Call-to-action
New Call-to-action
New Call-to-action

Travel + Hospitality

New Call-to-action
New Call-to-action
New Call-to-action

Have a challenge for us? We're here to help.

Contact Us >